Dysphagia and QoL 3 Years After Treatment of Oropharyngeal Cancer With TORS or Radiotherapy
The Laryngoscope · 2023-08 · 133 (8) · 1893-1898
DOI: 10.1002/lary.30410 ↗Kurz gefasst
Fachartikel in der Zeitschrift The Laryngoscope, online erschienen am 14.10.2022. Verfasst von Susanne Irene Scott und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Otorhinolaryngology, Head and Neck Surgery & Audiology, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark. Hauptthemen laut MEDLINE: Deglutition Disorders, Robotic Surgical Procedures, Oropharyngeal Neoplasms. Die Arbeit wurde bisher 16-mal zitiert (Crossref) und nennt 20 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Candys Foundation.
Themen: Dysphagie
Abstract (Originalsprache)
Objective(s) To investigate dysphagia and quality of life (QoL) outcomes 3 years after treatment of oropharyngeal cancer with either primary trans oral robotic surgery (TORS) or radiotherapy (RT).
Methods
A prospective cohort study conducted at the Copenhagen University Hospital. Endpoints were objective swallowing function, examined using fiberoptic endoscopic evaluation of swallowing (FEES) and video fluoroscopy (VF). QoL was assessed with the European Organization for Research and Treatment of Cancer Quality of Life Questionnaire Core (EORTC QLQ‐C30), Head & Neck Module (EORTC QLQ‐HN35), and MD Anderson Dysphagia Inventory (MDADI). A comparison was made between 1‐, and 3‐year results.
Results
Forty‐four patients were included prior to treatment, 31 treated with TORS and 13 with RT. One‐year results for this cohort have previously been published ( https://doi.org/10.1080/00016489.2020.1836395 ). Significant improvement on FEES in retention at the piriform sinus was noted in both groups. Patients treated with TORS had improved safety scores as well as dynamic imaging grade of swallowing toxicity (DIGEST) and efficiency scores, whereas patients treated with RT only had improvements in the latter two. Improvement in QoL scores was only noted for patients treated with TORS in composite MDADI scores.
Conclusion
We found significant improvements in objective swallowing function from one to 3 years after treatment, particularly in patients treated with TORS. However, these improvements were not reflected as clinically meaningful improvements in QoL. Level of Evidence 3, cohort follow‐up study Laryngoscope , 133:1893–1898, 2023
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Otorhinolaryngology, Head and Neck Surgery & Audiology, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark.
- Department of Diagnostic Radiology, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark.
- Department of Oncology, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark.
ORCID-Profile: Susanne Irene Scott
Förderung
- Candys Foundation
Zitieren
APA
Scott, S. I., Madsen, A. K. Ø., Rubek, N., Charabi, B. W., Wessel, I., Jensen, C. V., Friborg, J., & von Buchwald, C. (2023). Dysphagia and QoL 3 Years After Treatment of Oropharyngeal Cancer With TORS or Radiotherapy. The Laryngoscope, 133(8), 1893-1898. https://doi.org/10.1002/lary.30410
Vancouver
Scott SI, Madsen AKØ, Rubek N, Charabi BW, Wessel I, Jensen CV, et al. Dysphagia and QoL 3 Years After Treatment of Oropharyngeal Cancer With TORS or Radiotherapy. The Laryngoscope. 2023;133(8):1893-1898. doi:10.1002/lary.30410
BibTeX
@article{Scott2023,
author = {Scott, Susanne Irene and Madsen, Anne Kathrine Ø and Rubek, Niclas and Charabi, Birgitte Wittenborg and Wessel, Irene and Jensen, Claus V and Friborg, Jeppe and von Buchwald, Christian},
title = {Dysphagia and QoL 3 Years After Treatment of Oropharyngeal Cancer With TORS or Radiotherapy},
journal = {The Laryngoscope},
year = {2023},
volume = {133},
number = {8},
pages = {1893--1898},
doi = {10.1002/lary.30410}
}
EUVIMED